A 45-year-old patient presents with abnormal uterine bleeding and mild atypical hyperplasia of the endometrium. What is the treatment of choice?
A young woman who has suffered recurrent abortions presents with thrombosis of leg veins. What is the most likely diagnosis?
Hysteroscopy can be used to visualize which of the following?
A 25-year-old female patient presents with menorrhagia. On abdominal examination, an immobile mass is palpable. Pelvic examination reveals fixation of the uterus and adnexa. What is the most appropriate initial management for this patient?
A 40-year-old female complains of heavy menstrual bleeding and dysmenorrhoea. On ultrasound, an echogenic area suggestive of a 20-week pregnancy is seen within the uterus. Tenderness is present on examination. What is the most likely diagnosis?
Gartner's duct cyst is seen in which of the following locations?
Adenomyosis is defined as:
Which is the commonest type of ectopic pregnancy presenting with rupture?
Which of the following infections is associated with the presence of clue cells?
All are methods of managing fibroid uterus. Except-
Explanation: **Explanation:** The management of endometrial hyperplasia is determined by the presence or absence of **cellular atypia**, as atypia is the most significant predictor of progression to endometrial carcinoma. **1. Why Total Hysterectomy is the Correct Choice:** In a 45-year-old patient (perimenopausal) with **atypical hyperplasia**, the risk of progression to malignancy is approximately **29%**. Furthermore, there is a high co-existence rate (up to 40%) of an undetected concurrent endometrial carcinoma in patients diagnosed with atypia via biopsy. Therefore, **Total Hysterectomy** is the definitive treatment of choice for women who have completed their childbearing, as it eliminates the risk of progression and addresses potential occult malignancy. **2. Why Other Options are Incorrect:** * **Progesterone therapy (Option B):** This is the treatment of choice for hyperplasia **without** atypia. While it can be used for atypical hyperplasia in young patients wishing to preserve fertility, it requires stringent follow-up and is not the "treatment of choice" for a 45-year-old. * **Oral Contraceptive Pills (Option A):** OCPs contain estrogen, which is contraindicated as it further stimulates the endometrium. Progesterone-only therapy is required to oppose estrogenic effects. * **Estrogen therapy (Option D):** Unopposed estrogen is the primary etiological factor for endometrial hyperplasia; adding more would worsen the condition. **Clinical Pearls for NEET-PG:** * **Progression Risk (Kurman’s Classification):** * Simple Hyperplasia: 1% * Complex Hyperplasia: 3% * Simple Atypical Hyperplasia: 8% * **Complex Atypical Hyperplasia: 29%** * **Gold Standard Diagnosis:** Endometrial biopsy or D&C. * **Fertility Sparing:** If the patient desires pregnancy, high-dose Progestogens (Megestrol acetate) or Levonorgestrel-IUS (Mirena) can be used, followed by a repeat biopsy in 3 months.
Explanation: **Explanation:** The clinical presentation of **recurrent pregnancy loss (RPL)** combined with a **venous thromboembolic event** (leg vein thrombosis) is a classic hallmark of **Antiphospholipid Antibody Syndrome (APS)**. **1. Why Antiphospholipid Antibody Syndrome (APS) is correct:** APS is an autoimmune hypercoagulable state characterized by the presence of antiphospholipid antibodies (Lupus anticoagulant, Anti-cardiolipin, or Anti-β2 glycoprotein I). These antibodies induce a prothrombotic state by activating endothelial cells and platelets. In pregnancy, this leads to placental infarction and thrombosis of spiral arteries, resulting in recurrent abortions (typically after 10 weeks), while systemic involvement leads to venous or arterial thrombosis. **2. Why the other options are incorrect:** * **Chromosomal abnormality:** While this is the most common cause of *sporadic* first-trimester abortions, it does not cause maternal vascular thrombosis. * **Factor VIII deficiency:** This is Hemophilia A, a bleeding disorder. It would lead to excessive bleeding, not thrombosis. * **Increased antithrombin III levels:** Antithrombin III is a natural anticoagulant. *Increased* levels would decrease clotting risk; it is the *deficiency* of Antithrombin III that causes thrombosis. **Clinical Pearls for NEET-PG:** * **Sapporo Criteria:** Diagnosis requires at least one clinical criterion (vascular thrombosis or specific pregnancy morbidity) AND one laboratory criterion (positive APLA tests 12 weeks apart). * **Pregnancy Morbidity in APS:** ≥3 unexplained consecutive spontaneous abortions before 10th week; OR ≥1 premature birth (<34 weeks) due to eclampsia/preeclampsia/placental insufficiency; OR ≥1 unexplained fetal death ≥10th week. * **Management:** For pregnant women with APS and prior thrombosis, the standard treatment is **Low Molecular Weight Heparin (LMWH) plus Low-Dose Aspirin (LDA).**
Explanation: **Explanation:** Hysteroscopy is the "gold standard" for the direct visualization of the uterine cavity. It involves the insertion of an endoscope through the cervix, using a distension medium (like saline or CO2) to expand the cavity, allowing for both diagnostic and operative procedures. **Why "All the above" is correct:** * **Misplaced IUCD:** Hysteroscopy is the definitive method for locating an IUCD when the strings are not visible clinically. It allows for direct visualization and precise removal using hysteroscopic forceps, especially if the device is embedded in the endometrium. * **Submucosal Fibroid:** These are FIGO Type 0, 1, or 2 leiomyomas that protrude into the uterine cavity. Hysteroscopy is superior to ultrasound for identifying the degree of protrusion and can be used for surgical resection (Hysteroscopic Myomectomy). * **Uterine Synechiae (Asherman’s Syndrome):** Hysteroscopy is the diagnostic modality of choice to visualize intrauterine adhesions. It allows the surgeon to assess the extent, location, and nature of the adhesions while simultaneously performing adhesiolysis. **Clinical Pearls for NEET-PG:** * **Distension Media:** For diagnostic hysteroscopy, **Normal Saline** is preferred. For operative procedures using monopolar cautery, non-electrolytic fluids like **Glycine (1.5%)** or Mannitol are used. * **Contraindications:** Absolute contraindications include **active pelvic inflammatory disease (PID)** and **profuse uterine bleeding**. Pregnancy is also a contraindication unless performing embryoscopy. * **Timing:** The best time for a diagnostic hysteroscopy is the **early proliferative phase** (Day 6–10), as the endometrium is thin, providing the clearest view. * **Complication:** The most common complication is **uterine perforation**, while the most specific metabolic complication is **fluid overload/hyponatremia** (TURP-like syndrome) when using Glycine.
Explanation: **Explanation:** The clinical presentation of **menorrhagia**, an **immobile abdominal mass**, and **fixation of the uterus and adnexa** (often described as a "frozen pelvis") in a young female is highly suggestive of **Genital Tuberculosis (GTB)** or severe Endometriosis. In the Indian context, Genital TB is a leading cause of such findings. **Diagnostic Laparoscopy** is the gold standard for diagnosing Genital TB and assessing pelvic pathology. It allows for direct visualization of "millet-seed" tubercles, "beaded" tubes, or pelvic adhesions. Crucially, it enables the clinician to obtain a **directed biopsy** for histopathology and AFB culture, which is essential for a definitive diagnosis before starting long-term treatment. **Why other options are incorrect:** * **Tubal microsurgery:** This is a reconstructive procedure for infertility. It is contraindicated in the presence of active infection or extensive pelvic fixation. * **Anti-tubercular drugs (ATT):** While likely needed, ATT should not be started empirically without histological or microbiological confirmation, as the symptoms overlap with malignancy or endometriosis. * **Hysterectomy:** This is overly invasive and inappropriate for a 25-year-old patient desiring fertility, especially before a definitive diagnosis is established. **Clinical Pearls for NEET-PG:** * **Most common site for Genital TB:** Fallopian tubes (90-100%), followed by the Endometrium. * **Gold Standard Diagnosis:** Diagnostic Laparoscopy + Biopsy. * **Characteristic Laparoscopic findings:** "Tobacco pouch" appearance of tubes, beaded tubes, and Fitz-Hugh-Curtis syndrome (perihepatic adhesions). * **Infertility in GTB:** Usually due to tubal factor (obstruction) or endometrial receptivity issues.
Explanation: **Explanation:** The clinical presentation of heavy menstrual bleeding (menorrhagia), dysmenorrhea, and a significantly enlarged, tender uterus points towards a common benign gynecological condition. **Why Fibroid Uterus is Correct:** Uterine fibroids (leiomyomas) are the most common cause of a symmetrically or asymmetrically enlarged uterus. The description of a **"20-week pregnancy size"** is a classic NEET-PG clinical marker for a large fibroid. While fibroids are typically painless, they cause **tenderness** if they undergo **red degeneration** (common in pregnancy) or **torsion** of a pedunculated fibroid. On ultrasound, fibroids appear as well-defined, hypoechoic or echogenic masses. **Why Other Options are Incorrect:** * **Adenomyosis:** While it also presents with menorrhagia and dysmenorrhea, the uterus in adenomyosis is typically **globular** and rarely exceeds **12–14 weeks** in size. The tenderness is usually diffuse and cyclical. * **Endometriosis:** This primarily presents with chronic pelvic pain, infertility, and dysmenorrhea. While it can cause "fixed retroverted uterus," it does not typically cause massive uterine enlargement to a 20-week size. * **Pelvic Inflammatory Disease (PID):** PID presents with acute pelvic pain, vaginal discharge, and cervical motion tenderness. While the uterus may be tender, it is not significantly enlarged. **Clinical Pearls for NEET-PG:** * **Most common symptom of fibroid:** Menorrhagia (due to increased surface area of endometrium). * **Degenerations:** Red degeneration (carneous) is most common during the 2nd trimester of pregnancy due to rapid growth and ischemia. * **Investigation of choice:** Transvaginal Ultrasound (TVS); MRI is the most accurate for mapping. * **Size Correlation:** A uterus at the level of the umbilicus corresponds to 20–24 weeks of gestation.
Explanation: **Explanation:** **Gartner’s duct cysts** are the most common cystic lesions of the vagina. They are embryological remnants of the **Mesonephric (Wolffian) duct**. In females, the Wolffian ducts typically regress; however, if segments persist, they can become secretory and form cysts. These are characteristically located in the **anterolateral wall of the proximal (upper) third of the vagina**. **Analysis of Options:** * **Vagina (Correct):** As stated, these cysts arise from persistent vestigial remnants of the Wolffian duct specifically within the vaginal wall. * **Cervix (Incorrect):** Cysts in the cervix are most commonly **Nabothian cysts**, which are mucus-retention cysts formed due to the blockage of endocervical glands by squamous metaplasia. * **Hymen (Incorrect):** While hymenal cysts can occur (often congenital), they are not derived from Gartner’s duct remnants. * **Labia minora (Incorrect):** Cysts in the vulvar region/labia are typically **Bartholin’s cysts** (located at the 4 or 8 o'clock position of the vaginal orifice) or Sebaceous cysts. **Clinical Pearls for NEET-PG:** 1. **Origin:** Remnant of the Mesonephric (Wolffian) duct. (Mnemonic: **G**artner = **G**enitourinary/Wolffian). 2. **Location:** Anterolateral wall of the vagina, above the level of the hymen. 3. **Association:** Gartner’s duct cysts are occasionally associated with **congenital renal anomalies** (e.g., renal agenesis or ectopic ureter) because the ureteric bud also develops from the Wolffian duct. 4. **Histology:** They are lined by non-mucin producing cuboidal or low columnar epithelium. 5. **Symptomatology:** Usually asymptomatic and discovered incidentally, but large cysts may cause dyspareunia or difficulty in tampon insertion.
Explanation: **Explanation:** **Adenomyosis** is a common, benign gynecological condition characterized by the presence of **ectopic endometrial glands and stroma** within the myometrium (the muscular layer of the uterus). This infiltration leads to reactive hypertrophy and hyperplasia of the surrounding myometrium, resulting in a symmetrically enlarged, "globular," and boggy uterus. * **Why Option D is Correct:** By definition, adenomyosis involves the invasion of the basal layer of the endometrium into the myometrium (at least 2.5 mm below the endo-myometrial junction). Because these glands are responsive to hormonal changes, they bleed during menstruation, causing the classic symptoms of secondary dysmenorrhea and menorrhagia. * **Why Options A, B, and C are Incorrect:** * **Option A:** Adenomyosis is not a true neoplastic tumor; it is a benign migration of tissue. While it can form a localized mass called an *adenomyoma*, it is distinct from tumors like leiomyomas (fibroids). * **Option B & C:** Adenomyosis is **not** a malignant or pre-malignant condition. It is a benign process and does not typically progress to uterine cancer. **NEET-PG High-Yield Pearls:** * **Classic Triad:** Secondary dysmenorrhea, menorrhagia (heavy menstrual bleeding), and a symmetrically enlarged, soft/boggy uterus. * **Diagnosis:** Transvaginal Ultrasound (TVUS) is the first-line investigation (shows "venetian blind" shadowing or asymmetrical wall thickening). **MRI** is the gold standard for diagnosis. * **Histology:** The definitive diagnosis is made via histopathology after a hysterectomy. * **Management:** Levonorgestrel-releasing intrauterine system (LNG-IUS) is the medical treatment of choice; Hysterectomy is the definitive treatment.
Explanation: **Explanation:** The correct answer is **Isthmic (Option A)**. The site of ectopic pregnancy significantly influences the timing and likelihood of rupture based on the anatomical diameter and distensibility of the Fallopian tube. 1. **Why Isthmic is correct:** The **isthmus** is the narrowest part of the Fallopian tube with a thick, muscular wall and minimal distensibility. Because the lumen is so small, the growing embryo quickly outgrows the space, leading to **early rupture**, typically between 6 to 8 weeks of gestation. While the ampulla is the most common site for ectopic pregnancy overall, the isthmus is the site most likely to present with an acute rupture. 2. **Why other options are incorrect:** * **Ampulla (B):** This is the most common site for ectopic pregnancy (approx. 70%). However, because the ampulla is wider and more distensible, it often results in a "tubal abortion" or a delayed rupture (8–12 weeks) rather than an early, acute rupture. * **Interstitial (C):** This is the most dangerous site. Because it is surrounded by thick myometrium, it can distend significantly, rupturing late (12–16 weeks). When it does rupture, it causes massive, life-threatening hemorrhage. * **Infundibular (D):** This is the least common site and usually results in tubal abortion into the peritoneal cavity. **High-Yield NEET-PG Pearls:** * **Most common site of Ectopic Pregnancy:** Ampulla. * **Most common site of Ruptured Ectopic:** Isthmus. * **Most common site of Tubal Abortion:** Ampulla. * **Site with highest mortality/most severe hemorrhage:** Interstitial (Cornual). * **Classic Triad:** Amenorrhea, abdominal pain, and vaginal bleeding (present in only 50% of cases).
Explanation: **Explanation:** **Bacterial Vaginosis (BV)** is the correct answer. It is a clinical syndrome resulting from a shift in the vaginal flora where normal hydrogen peroxide-producing *Lactobacilli* are replaced by anaerobic bacteria (e.g., *Gardnerella vaginalis*, *Mobiluncus*, and *Mycoplasma hominis*). **Clue cells** are the pathognomonic microscopic finding in BV; they are vaginal epithelial cells covered with so many coccobacilli that their borders become "stippled" or obscured. **Analysis of Incorrect Options:** * **HSV 2 infection:** Characterized by painful vesicles and ulcers. Tzanck smear would show multinucleated giant cells and Cowdry type A inclusion bodies, not clue cells. * **Syphilis:** Primary syphilis presents with a painless chancre. Diagnosis is via dark-field microscopy (showing *Treponema pallidum*) or serology (VDRL/RPR). * **Trichomoniasis:** Caused by a protozoan. Microscopy reveals motile, flagellated trichomonads and an abundance of polymorphonuclear leukocytes (PMNs). It is often associated with a "strawberry cervix." **NEET-PG High-Yield Pearls:** * **Amsel’s Criteria (3 out of 4 required for BV diagnosis):** 1. Homogeneous, thin, white-grey discharge. 2. Vaginal pH > 4.5 (Most sensitive). 3. Positive **Whiff test** (fishy odor on adding 10% KOH). 4. Presence of **Clue cells** on wet mount (Most specific). * **Nugent Scoring:** The gold standard for BV diagnosis (based on Gram stain). * **Treatment:** Drug of choice is **Metronidazole** (500 mg BID for 7 days). Note: Partner treatment is not routinely recommended for BV, unlike Trichomoniasis.
Explanation: **Explanation:** The management of uterine fibroids (leiomyomas) is categorized into surgical, minimally invasive, and medical interventions. The correct answer is **Radiofrequency Ablation (RFA)** because, while it is an emerging technology, it is currently primarily used for the destruction of small, localized tumors (like osteoid osteoma or hepatic nodules) and is **not** a standard or conventional method for managing a fibroid uterus in typical clinical practice or standard textbooks (like Williams or Shaw). * **Option A (Myomectomy):** This is the gold standard surgical treatment for women who wish to preserve fertility. It involves the surgical removal of individual fibroids while leaving the uterus intact. * **Option C (Uterine Artery Embolization - UAE):** A well-established minimally invasive procedure where polyvinyl alcohol particles are injected into the uterine arteries to cut off the blood supply to the fibroids, leading to ischemic necrosis and shrinkage. * **Option D (Laser Myomectomy):** This refers to the use of Nd:YAG or CO2 lasers during laparoscopic or hysteroscopic surgery to excise or vaporize fibroid tissue. It is a recognized surgical variant of a standard myomectomy. **High-Yield Clinical Pearls for NEET-PG:** * **Medical Management:** Combined Oral Contraceptive Pills (OCPs) are the first-line for symptomatic relief (bleeding), while **GnRH agonists** (e.g., Leuprolide) are used pre-operatively to reduce fibroid size and vascularity. * **Ulipristal Acetate:** A Selective Progesterone Receptor Modulator (SPRM) used for medical management, though monitored closely for liver toxicity. * **Definitive Treatment:** Hysterectomy remains the only definitive cure for fibroids in women who have completed their family. * **Red Degeneration:** The most common complication of fibroids during pregnancy, managed conservatively with analgesics.
Abnormal Uterine Bleeding
Practice Questions
Endometriosis
Practice Questions
Adenomyosis
Practice Questions
Uterine Fibroids
Practice Questions
Ovarian Cysts
Practice Questions
Pelvic Inflammatory Disease
Practice Questions
Vulvovaginitis
Practice Questions
Pelvic Organ Prolapse
Practice Questions
Vulvar Disorders
Practice Questions
Benign Breast Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free